Hansa Biopharma AB (HNSA) — Net Asset Momentum
Hansa Biopharma AB (HNSA) recorded a net asset momentum of -251.4% as of December 2024, with net assets of Skr-589.83 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Hansa Biopharma AB defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Hansa Biopharma AB Net Asset Momentum (2008–2024)
This chart tracks Hansa Biopharma AB's year-over-year net asset growth across 17 annual reporting periods from 2008 to 2024. The most recent momentum reading is -251.4%, with net assets of Skr-589.83 Million SEK as of December 2024. Read HNSA total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Hansa Biopharma AB (2008–2024)
The table below shows the complete annual net asset history for Hansa Biopharma AB from 2008 to 2024, covering 17 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Hansa Biopharma AB (HNSA) market capitalisation.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | Skr-589.83 Million | Skr800.64 Million | Skr1.39 Billion | ▼ -251.4% |
| 2023 | Skr-167.88 Million | Skr1.02 Billion | Skr1.19 Billion | ▼ -127.8% |
| 2022 | Skr602.91 Million | Skr1.69 Billion | Skr1.08 Billion | ▼ -20.4% |
| 2021 | Skr757.57 Million | Skr1.01 Billion | Skr255.24 Million | ▼ -39.0% |
| 2020 | Skr1.24 Billion | Skr1.43 Billion | Skr192.37 Million | ▲ +120.7% |
| 2019 | Skr562.82 Million | Skr664.24 Million | Skr101.42 Million | ▼ -34.5% |
| 2018 | Skr859.88 Million | Skr944.82 Million | Skr84.94 Million | ▲ +36.3% |
| 2017 | Skr630.66 Million | Skr680.41 Million | Skr49.75 Million | ▲ +122.3% |
| 2016 | Skr283.69 Million | Skr310.67 Million | Skr26.98 Million | ▲ +34.1% |
| 2015 | Skr211.53 Million | Skr224.09 Million | Skr12.56 Million | ▲ +324.7% |
| 2014 | Skr49.80 Million | Skr54.31 Million | Skr4.51 Million | ▲ +9.0% |
| 2013 | Skr45.68 Million | Skr50.78 Million | Skr5.10 Million | ▼ -27.8% |
| 2012 | Skr63.24 Million | Skr65.80 Million | Skr2.56 Million | ▲ +82.2% |
| 2011 | Skr34.71 Million | Skr40.90 Million | Skr6.19 Million | ▲ +7.9% |
| 2010 | Skr32.17 Million | Skr37.80 Million | Skr5.64 Million | ▲ +29.1% |
| 2009 | Skr24.92 Million | Skr38.15 Million | Skr13.23 Million | ▼ -38.8% |
| 2008 | Skr40.73 Million | Skr44.87 Million | Skr4.13 Million | — |